Collateral sensitivity to azidothymidine in methotrexate resistant human leukemia cells

H. Miyachi, L. Jiao, Lawrence Sowers, K. J. Scanlon

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Resistance to methotrexate (MTX) is a well established clinical problem and strategies to circumvent this would obviously be beneficial. The human leukemia cell line, CCRF-CEM, was grown in folinic acid to study MTX resistance-reflecting more in vivo conditions. A 15.8-fold resistant subline, CEM/MTX, was evolved by stepwise increases in MTX exposure. The MTX resistant cell line exhibited both increased dihydrofolate reductase (DHFR) activity due to gene amplification as well as impaired MTX uptake. An additional mechanism of resistance to MTX was a 2-fold increase in thymidine kinase (TK). As a result of this increased TK activity, the CEM/MTX cells were collaterally sensitive to the nucleoside analogue, azidothymidine (AZT). CEM cells resistant to MTX possess properties that can be exploited by AZT and these studies may have clinical implications.

Original languageEnglish (US)
Pages (from-to)17-21
Number of pages5
JournalIn Vivo
Volume6
Issue number1
StatePublished - 1992
Externally publishedYes

Fingerprint

Zidovudine
Methotrexate
Leukemia
Thymidine Kinase
Cells
Cell Line
Tetrahydrofolate Dehydrogenase
Leucovorin
Gene Amplification
Nucleosides

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Collateral sensitivity to azidothymidine in methotrexate resistant human leukemia cells. / Miyachi, H.; Jiao, L.; Sowers, Lawrence; Scanlon, K. J.

In: In Vivo, Vol. 6, No. 1, 1992, p. 17-21.

Research output: Contribution to journalArticle

Miyachi, H, Jiao, L, Sowers, L & Scanlon, KJ 1992, 'Collateral sensitivity to azidothymidine in methotrexate resistant human leukemia cells', In Vivo, vol. 6, no. 1, pp. 17-21.
Miyachi, H. ; Jiao, L. ; Sowers, Lawrence ; Scanlon, K. J. / Collateral sensitivity to azidothymidine in methotrexate resistant human leukemia cells. In: In Vivo. 1992 ; Vol. 6, No. 1. pp. 17-21.
@article{8675762fa7cb433f97030f637afb6861,
title = "Collateral sensitivity to azidothymidine in methotrexate resistant human leukemia cells",
abstract = "Resistance to methotrexate (MTX) is a well established clinical problem and strategies to circumvent this would obviously be beneficial. The human leukemia cell line, CCRF-CEM, was grown in folinic acid to study MTX resistance-reflecting more in vivo conditions. A 15.8-fold resistant subline, CEM/MTX, was evolved by stepwise increases in MTX exposure. The MTX resistant cell line exhibited both increased dihydrofolate reductase (DHFR) activity due to gene amplification as well as impaired MTX uptake. An additional mechanism of resistance to MTX was a 2-fold increase in thymidine kinase (TK). As a result of this increased TK activity, the CEM/MTX cells were collaterally sensitive to the nucleoside analogue, azidothymidine (AZT). CEM cells resistant to MTX possess properties that can be exploited by AZT and these studies may have clinical implications.",
author = "H. Miyachi and L. Jiao and Lawrence Sowers and Scanlon, {K. J.}",
year = "1992",
language = "English (US)",
volume = "6",
pages = "17--21",
journal = "In Vivo",
issn = "0258-851X",
publisher = "International Institute of Anticancer Research",
number = "1",

}

TY - JOUR

T1 - Collateral sensitivity to azidothymidine in methotrexate resistant human leukemia cells

AU - Miyachi, H.

AU - Jiao, L.

AU - Sowers, Lawrence

AU - Scanlon, K. J.

PY - 1992

Y1 - 1992

N2 - Resistance to methotrexate (MTX) is a well established clinical problem and strategies to circumvent this would obviously be beneficial. The human leukemia cell line, CCRF-CEM, was grown in folinic acid to study MTX resistance-reflecting more in vivo conditions. A 15.8-fold resistant subline, CEM/MTX, was evolved by stepwise increases in MTX exposure. The MTX resistant cell line exhibited both increased dihydrofolate reductase (DHFR) activity due to gene amplification as well as impaired MTX uptake. An additional mechanism of resistance to MTX was a 2-fold increase in thymidine kinase (TK). As a result of this increased TK activity, the CEM/MTX cells were collaterally sensitive to the nucleoside analogue, azidothymidine (AZT). CEM cells resistant to MTX possess properties that can be exploited by AZT and these studies may have clinical implications.

AB - Resistance to methotrexate (MTX) is a well established clinical problem and strategies to circumvent this would obviously be beneficial. The human leukemia cell line, CCRF-CEM, was grown in folinic acid to study MTX resistance-reflecting more in vivo conditions. A 15.8-fold resistant subline, CEM/MTX, was evolved by stepwise increases in MTX exposure. The MTX resistant cell line exhibited both increased dihydrofolate reductase (DHFR) activity due to gene amplification as well as impaired MTX uptake. An additional mechanism of resistance to MTX was a 2-fold increase in thymidine kinase (TK). As a result of this increased TK activity, the CEM/MTX cells were collaterally sensitive to the nucleoside analogue, azidothymidine (AZT). CEM cells resistant to MTX possess properties that can be exploited by AZT and these studies may have clinical implications.

UR - http://www.scopus.com/inward/record.url?scp=0026591039&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026591039&partnerID=8YFLogxK

M3 - Article

C2 - 1385729

AN - SCOPUS:0026591039

VL - 6

SP - 17

EP - 21

JO - In Vivo

JF - In Vivo

SN - 0258-851X

IS - 1

ER -